Middle East & Africa Digital PCR and Real-Time PCR Market Overview, Growth, Trends, Analysis, Research Report (2025-2031)

The Middle East & Africa Digital PCR and Real-Time PCR Market size is expected to reach US$ 1,009.1 Million by 2031 from US$ 589.9 Million in 2024. The market is estimated to record a CAGR of 8.0% from 2025 to 2031.

Executive Summary and Middle East & Africa Digital PCR and Real-Time PCR Market Analysis:

The digital PCR and real-time PCR market in the Middle East & Africa is set to experience significant growth over the next few years. The growth in these markets will initially be driven by the expansion of diagnostic capabilities in the region as well as the continuous advancements in laboratory technologies. As the regional markets China will lead the regional markets like United Arab Emirates, Saudi Arabia, and South Africa supported by increasing investments in healthcare infrastructure and biotechnology research.

The creation of advanced reagent systems, the implementation of fully automatic platforms, and the upgrading of high-precision instruments have all contributed to the efficiency and accuracy of molecular diagnostics in this region. Besides that, the rise in accessibility to a wide variety of innovative PCR-based products for diagnostic and research laboratories is creating a strong demand for the market. The raising awareness about the technology and its utilization in the detection and management of diseases through the organized scientific conferences, workshops, and symposia has also contributed in a significant way to the market.
In addition to government initiatives aimed at modernizing healthcare systems and promoting biomedical research, these factors are expected to fuel the growth of the digital PCR and real-time PCR market across the Middle East and Africa.

Middle East & Africa Digital PCR and Real-Time PCR Market: Strategic Insights

Middle East & Africa Digital PCR and Real-Time PCR Market Segmentation Analysis:

• By Product and Services, the Middle East & Africa Digital PCR and Real-Time PCR Market is segmented into Instruments, Reagents and Consumables, and Software and Services. Reagents and Consumables held the largest share of the market in 2024.
• By Applications, the Middle East & Africa Digital PCR and Real-Time PCR Market is segmented into Infectious Diseases Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Others. Infectious Diseases Testing held the largest share of the market in 2024.
• By End User, the Middle East & Africa Digital PCR and Real-Time PCR Market is segmented into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories. Hospitals and Diagnostic Centers held the largest share of the market in 2024.
• By Type, the Middle East & Africa Digital PCR and Real-Time PCR Market is segmented into Digital PCR and Real-Time PCR. Real-time PCR held the largest share of the market in 2024.

Middle East & Africa Digital PCR and Real-Time PCR Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Digital PCR and Real-Time PCR Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East & Africa Digital PCR and Real-Time PCR Market Outlook

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, over 15,500 people are diagnosed with genetic disorders each year. The adoption of digital PCR is improving as pathologists are trying to use this technology to target various specific DNA sequences and diagnose and design various clinical tests. Digital PCR can target specific DNA sequences in just one molecule of DNA. This new tool allows researchers to isolate rare genetic mutations that are too difficult to segregate with real-time PCR.

The COVID-19 outbreak had a significant effect on the digital PCR and real-time PCR market growth. The growing demand from clinical diagnostics has a favorable effect on the PCR industry. Almost all diagnostic tests utilized RT-PCR to test individuals with COVID-19 symptoms, and healthcare experts recommended that they undergo diagnostic testing. However, authorities did not endorse viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. The portfolio includes the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium--, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Moreover, nations or settings where larger equipment cannot be accommodated due to the lack of resources or space can have access to better testing due to this system.

Thus, the increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatment supports the growth of the digital PCR and real-time PCR market.

Middle East & Africa Digital PCR and Real-Time PCR Market Country Insights

By country, the Middle East & Africa Digital PCR and Real-Time PCR Market is segmented into South Africa, Saudi Arabia, the United Arab Emirates, Rest of Middle East & Africa. Saudi Arabia held the largest share in 2024.

Genetic diseases are common in Saudi Arabia, primarily due to consanguineous marriage. Thus, the increase in premarital genetic screening is advised in the country, which drives the digital PCR and real-time PCR market growth in this country. The Government of Saudi Arabia has made it mandatory to undergo premarital genetic screening before marriage to check genetic compatibility to reduce hereditary blood diseases such as sickle cell and beta-thalassemia, which are most prevalent in the country. Therefore, the rising prevalence of genetic diseases and increasing premarital genetic testing drive the market growth in Saudi Arabia. Also, the growing number of cancer cases has fueled cancer research in Saudi Arabia. As per GLOBOCAN 2022 data, the country recorded ~28,113 new cancer cases. The 5-year prevalence rate for cancer in all ages was found to be 237.4 per 100,000 people, which, in turn, propels the demand for digital PCR and real-time PCR for diagnosis purposes in Saudi Arabia.

Middle East & Africa Digital PCR and Real-Time PCR Market Company Profiles

Some of the key players operating in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Agilent Technologies Inc, Takara Bio Inc, Danaher Corp, Countable Labs.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Digital PCR and Real-Time PCR Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise